R-CODOX-M Alternating with R-IVAC Regimen

Preferred Label : R-CODOX-M Alternating with R-IVAC Regimen;

NCIt synonyms : Rituximab/Cyclophosphamide/Vincristine/Doxorubicin/Methotrexate and Rituximab/Ifosfamide/Etoposide/Cytarabine; Rituximab/Cyclophosphamide/Oncovin/Doxorubicin/Methotrexate and Rituximab/Ifosfamide/VePesid/AraC Regimen; R-CODOX-M Alternating With R-IVAC; R-CODOX-M/R-IVAC Regimen; R-IVAC R-CODOX-M;

NCIt related terms : R-CODOX-M/R-IVAC (rituximab-pvvr); R-CODOX-M/R-IVAC (rituximab-blit); R-CODOX-M/R-IVAC (rituximab-rixa); R-CODOX-M/R-IVAC (rituximab-abbs); R-CODOX-M/R-IVAC (rituximab-rite); R-CODOX-M/R-IVAC (rituximab-rixi); R-CODOX-M/R-IVAC; R-CODOX-M/R-IVAC (rituximab-arrx);

NCIt definition : A regimen consisting of rituximab, cyclophosphamide, vincristine, doxorubicin and high-dose methotrexate (R-CODOX-M) alternating with rituximab, ifosfamide, etoposide and high-dose cytarabine (R-IVAC) that may be used in the treatment of non-Hodgkin lymphoma (NHL), including Burkitt lymphoma.;

NCI Metathesaurus CUI : CL969496;

Codes from synonyms : 128359; 127888; 128516; 128673; 10647; 128202; 127731; 128045;

Details

Origin ID

C160570;

UMLS CUI

C5205365;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Cytarabine [NCIt concept]
- Doxorubicin Hydrochloride [NCIt concept]
- Etoposide [NCIt concept]
- Ifosfamide [NCIt concept]
- Methotrexate Sodium [NCIt concept]
- Rituximab [NCIt concept]
- Vincristine Sulfate [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients